The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of long-term outcomes for neoadjuvant chemoradiation (NA-CRT) followed by surgery versus (V) definitive chemoradiation (D-CRT) in localized gastroesophageal cancer (GEC): A single-center analysis.
 
Ronan McLaughlin
No Relationships to Disclose
 
Divya Sharma
No Relationships to Disclose
 
Yvonne Bach
No Relationships to Disclose
 
Abdul Farooq
No Relationships to Disclose
 
Nadia Ghazali
No Relationships to Disclose
 
Harry Harvey
No Relationships to Disclose
 
Zac Coyne
No Relationships to Disclose
 
Hiroko Aoyama
No Relationships to Disclose
 
Sokaina Akhtar
No Relationships to Disclose
 
Raymond Jang
Research Funding - AstraZeneca (Inst); Camurus (Inst); Merck (Inst)
 
Eric Chen
Honoraria - AstraZeneca Canada; Eisai; GlaxoSmithKline; Merck; Pfizer; Roche; Takeda
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Repare Therapeutics; Roche Canada
 
Lucy Ma
Consulting or Advisory Role - Eisai
 
Sangeetha Kalimuthu
No Relationships to Disclose
 
Patrick Veit-Haibach
No Relationships to Disclose
 
Rebecca KS Wong
Honoraria - Elekta (Inst); Novartis
Research Funding - Bruce Power (Inst); Celgene/Bristol-Myers Squibb (Inst); POINT Biopharma (Inst); Precirix (Inst)
 
Aruz Mesci
No Relationships to Disclose
 
Michael Yan
No Relationships to Disclose
 
Elliot Wakeam
No Relationships to Disclose
 
Jonathan Yeung
No Relationships to Disclose
 
Elena Elimova
Employment - Merck (I)
Honoraria - Roche Canada
Consulting or Advisory Role - Abbvie; Adaptimmune (Inst); Astellas Pharma; BeiGene (Inst); Bristol-Myers Squibb (Inst); Signatera; Viracta Therapeutics; Zymeworks (Inst)
Research Funding - Arcus Biosciences (Inst); AstraZeneca Canada (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Jazz Pharmaceuticals (Inst); Zymeworks (Inst)